Selective sodium iodide symporter (<i>NIS</i>) genetherapy of glioblastoma mediatedby EGFR-targeted lipopolyplexes.

Mol Ther Oncolytics · 2021 · PMC8604759 · PMID 34853814

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The therapy group showed a trend toward the lowest number of Ki67-positive cells ( Figure 6 E) and a significantly smaller area of CD31 positivity ( Figure 6 F) compared with the control groups.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.